Empagliflozin/Metformin Hcl
Brand name: Synjardy Xr
Rank #135 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$119.7M
Total Cost
121,366
Total Claims
$119.7M
Total Cost
4,067
Prescribers
$986
Cost per Claim
14,319
Beneficiaries
205,365
30-Day Fills
$29K
Avg Cost/Provider
30
Avg Claims/Provider
Share of Medicare Part D Spending
0.04%
of total Medicare Part D spending
$119.7M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $119.7M total
🔎 Data Overview
Average cost of $8,357 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Empagliflozin/Metformin Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Phong Bui | Internal Medicine | Fountain Valley, CA | 853 | $1.0M |
| 2 | Iraklii Buziashvili | Endocrinology | Brooklyn, NY | 1,308 | $957K |
| 3 | Manuel Alegre-Hernandez | Endocrinology | San Juan, PR | 807 | $854K |
| 4 | Enrique Griego | Family Practice | Mcallen, TX | 557 | $746K |
| 5 | Edwin Torres | Nurse Practitioner | New York, NY | 455 | $593K |
| 6 | Sheila Mercado | Endocrinology | Manati, PR | 795 | $546K |
| 7 | Alejandra Santiago | Endocrinology | Ponce, PR | 795 | $505K |
| 8 | Benjamin Prohaska | Physician Assistant | Reno, NV | 382 | $494K |
| 9 | Rafael Rodriguez | Internal Medicine | Jackson Heights, NY | 349 | $485K |
| 10 | Sergio Rovner | Endocrinology | El Paso, TX | 377 | $475K |
| 11 | Duc Phan | Internal Medicine | Houston, TX | 443 | $464K |
| 12 | Lisen Liu | Endocrinology | Flushing, NY | 753 | $457K |
| 13 | Daniela Dicenso | Internal Medicine | Miami, FL | 598 | $394K |
| 14 | Jamil Abouelhossen | Internal Medicine | Fajardo, PR | 384 | $394K |
| 15 | Jose Zavaleta | Endocrinology | Houston, TX | 241 | $375K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 132 | Dronedarone Hcl (Multaq) | $123.4M | 98,156 |
| 133 | Brimonidine Tartrate/Timolol (Brimonidine Tartrate-Timolol) | $122.0M | 361,001 |
| 134 | Olaparib (Lynparza) | $121.1M | 8,744 |
| 135 | Empagliflozin/Metformin Hcl (Synjardy Xr) | $119.7M | 121,366 |
| 136 | Edaravone (Radicava Ors) | $119.6M | 8,588 |
| 137 | Insulin Regular, Human (Afrezza) | $119.4M | 143,017 |
| 138 | Ezetimibe (Ezetimibe) | $118.1M | 2,859,001 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology